Clinical Trial Update: CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study [Phase 3]

View source ↗

Summary

The CLEARI Phase 3 trial assessing clinical efficacy for recurrent upper respiratory tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infections

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Recurrent Upper-Respiratory Tract Infections | Phase 3 | Status: COMPLETED